Recent Updates
Recently added Catalysts
AMGN Positive Sentiment

AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

Key Takeaway: Amgen will present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026. Key executives, including Jay Bradner and Thomas Dittrich, will discuss the company's developments. The presentation will be available via webcast for the public and investors, with an archive accessible for 90 days post-event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Amgen will showcase its advancements at a major healthcare conference.
  • The event will be accessible to a wide audience via webcast.
  • Amgen's leadership will present insights on the company's innovations.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+30%
120-day peak, hindsight
Typical move
1.4%
average across 15 past catalysts
Lead asset
Maridebart cafraglutide
Phase 3 · Obesity Disease

Full Press Release Details

THOUSAND OAKS, Calif., Sept. 9, 2026 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the Morgan Stanley 24 th Annual Global Healthcare Conference at 11:30 a.m. ET on Tuesday, September 15, 2026. Jay Bradner, executive vice president, Research and Development, Artificial Intelligence and Data at Amgen, and Thomas Dittrich, executive vice president and chief financial officer at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines.
More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, inflammatory conditions, rare diseases, heart disease and obesity and obesity-related conditions.
Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ®, and it is also part of the Nasdaq-100 Index ®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn, Instagram, YouTube and Threads.

Frequently Asked Questions

When will Amgen present at the conference?

Amgen will present on September 15, 2026, at 11:30 a.m. ET.

Who will represent Amgen at the conference?

Jay Bradner and Thomas Dittrich will represent Amgen.

How can the public access the presentation?

The presentation will be available via a live webcast on Amgen's website.

How long will the webcast be available for replay?

The webcast will be archived and available for replay for at least 90 days.

Last updated: Sep 9, 2026